Literature DB >> 10416734

Glucose-induced increase in memory performance in patients with schizophrenia.

J W Newcomer1, S Craft, R Fucetola, S O Moldin, G Selke, L Paras, R Miller.   

Abstract

Previous investigations have found that increasing circulating glucose availability can increase memory performance in rodents, healthy humans, and individuals with dementia of the Alzheimer's type. In this study, patients with schizophrenia, healthy control subjects, and controls with bipolar affective disorder were tested using double-blind treatment with either 50 g anhydrous dextrose plus 4 mg sodium saccharin (for "taste") or 23.7 mg saccharin alone, followed by cognitive testing on a complex battery. At this glucose dose, verbal memory performance on a paragraph recall task was increased during the glucose condition relative to the saccharin condition in the patients with schizophrenia; this effect was not detected in either the psychiatric or normal controls. The results provide preliminary support for the hypothesis that memory performance can be improved in patients with schizophrenia by increasing circulating glucose availability and suggest the importance of further evaluation of therapeutic manipulations of glucose availability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416734     DOI: 10.1093/oxfordjournals.schbul.a033381

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  23 in total

Review 1.  Schizotaxia: current status and future directions.

Authors:  Ming T Tsuang; William S Stone; Franziska Gamma; Stephen V Faraone
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 2.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Differential effects of glucose on modulation of emotional and nonemotional spatial memory tasks.

Authors:  A Mohanty; R W Flint
Journal:  Cogn Affect Behav Neurosci       Date:  2001-03       Impact factor: 3.282

Review 4.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

5.  Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia.

Authors:  Dwight Dickinson; James M Gold
Journal:  Schizophr Bull       Date:  2007-08-16       Impact factor: 9.306

6.  A tale of two stories: Validity of an alternative story memory test in a sample of older adults.

Authors:  Erin Trifilio; Jared J Tanner; London Butterfield; Paul Mangal; Jacqueline E Maye; Michael Marsiske; Catherine C Price; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2019-01-12       Impact factor: 3.535

7.  Brain insulin resistance and altered brain glucose are related to memory impairments in schizophrenia.

Authors:  S Andrea Wijtenburg; Dimitrios Kapogiannis; Stephanie A Korenic; Roger J Mullins; Joyce Tran; Frank E Gaston; Shuo Chen; Maja Mustapic; L Elliot Hong; Laura M Rowland
Journal:  Schizophr Res       Date:  2019-02-11       Impact factor: 4.939

Review 8.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.

Authors:  Oded Bergman; Dorit Ben-Shachar
Journal:  Can J Psychiatry       Date:  2016-08       Impact factor: 4.356

9.  Relationship between changes in metabolic syndrome constituent components over 12 months of treatment and cognitive performance in first-episode schizophrenia.

Authors:  H K Luckhoff; S Kilian; M R Olivier; L Phahladira; F Scheffler; S du Plessis; B Chiliza; L Asmal; R Emsley
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

10.  S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance.

Authors:  Johann Steiner; Aye Mu Myint; Kolja Schiltz; Sabine Westphal; Hans-Gert Bernstein; Martin Walter; Matthias L Schroeter; Markus J Schwarz; Bernhard Bogerts
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.